Researchers trial self-administration of flu vaccine; Sinovac publishes PhIII data in NEJM;

> A study has found self-administration of the flu vaccine using microneedle patches may be feasible. Research

> Sinovac has published data from a Phase III trial of its hand, foot and mouth disease vaccine in the NEJM. Release

> Academics are working with two pharmaceutical companies to translate their dengue virus breakthrough into a vaccine. Item

> The WHO is to help vaccinate 140,000 people in South Sudan against cholera. News

> The CDC has made no changes to its flu vaccine recommendations for 2014-2015. Article

> TheStreet's Adam Feuerstein has assessed the likelihood of NewLink Genetic's ($NLNK) pancreatic cancer vaccine winning approval. Feature

> Bavarian Nordic has won a U.S. Department of Defense contract to develop a vaccine against two biological threats. Item

> An investigation into an adverse event following use of Novartis' ($NVS) Bexsero at Princeton University suggests the vaccine was unlikely to have been the cause. Piece

> Vietnam is importing almost 80,000 doses of the chickenpox vaccine to tackle an epidemic. News

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.